858 Therapeutics: Revenue, Competitors, Alternatives - Growjo

858 Therapeutics 's estimated revenue per employee is $ 77,500Employee Data. 858 Therapeutics has 34 Employees. ... 858 Therapeutics Competitors & AlternativesAdd Company. Competitor Name Revenue Number of Employees Employee Growth Total Funding Valuation …

CouponFollow Extension

$80.06
OFF

858 Therapeutics Company Profile - Office Locations, Competitors ...

6 days from now

858 Therapeutics has 1 employees at their 1 location and $80.06 m in total funding,. See insights on 858 Therapeutics including office locations, competitors, revenue, financials, executives, …

craft.co

$60
OFF

858 Therapeutics Raises $60 Million - Chemical & Engineering News

6 days from now

Sep 24, 2021 · 858 Therapeutics has launched with $60 million in series A financing to develop small-molecule cancer drugs. The San Diego-based start-up also acquired Gotham …

acs.org

$60
OFF

858 Therapeutics Launches With $60 Million And Acquisition Of …

6 days from now

Sep 20, 2021 · The new company will advance Gotham’s lead epitranscriptomics program focused on METTL3. After operating for more than 2 years in stealth, the biotech startup 858 …

acs.org

$60
OFF

Wilson Sonsini Represents New Enterprise Associates And Versant ...

6 days from now

On September 22, 2021, 858 Therapeutics announced the completion of a $60 million Series A financing led by founding investor Versant Ventures, with participation from NEA, Cormorant …

wsgr.com

$60
OFF

Calling San Diego: 858 Therapeutics Closes $60M Series A Round To …

6 days from now

Sep 21, 2021 · 858 Therapeutics Inc. emerged from stealth mode, unveiling $60 million in series A funding and plans to drug a series of protein targets involved in modulating RNA biology in …

bioworld.com

FAQs about 858 Therapeutics: Revenue, Competitors, Alternatives - Growjo Coupon?

Who is 858 Therapeutics?

858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology. View contacts for 858 Therapeutics to access new leads and connect with decision-makers. 858 Therapeutics is a stealth company specializing in the area of healthcare services, pharmaceutical, and biotechnology. ...

Where is 858 Therapeutics headquarters?

Where is 858 Therapeutics 's headquarters? 858 Therapeutics is located in San Diego, California, United States. Who invested in 858 Therapeutics? 858 Therapeutics has 4 investors including New Enterprise Associates and Cormorant Asset Management. ...

Has 858 Therapeutics acquired Gotham Therapeutics?

858 Therapeutics has acquired Gotham Therapeutics, based in New York City, for an undisclosed sum. Gotham is focused on epitranscriptomics, the study of chemical modifications of RNA. In addition to its own drug discovery programs, 858’s pipeline will get a boost through this acquisition. ...

Will METTL3 funding help 858's lead program?

The financing from METTL3 should help advance 858 Therapeutics' lead programs, including the METTL3 program from their acquired company Gotham, into the clinic by 2023. ...